Tumorigenesis-associated pathways, such as the ERBB signaling pathway, MAPK signaling pathway, Toll-like receptor signaling pathway, and non-small cell lung cancer, were also predicted in the high JAK1 expression group. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.